Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
12/26/2001 | CN1327849A Composite Chinese medicine for treating lung diseases |
12/26/2001 | CN1327846A Medicine for treating throat diseases and its preparing process |
12/26/2001 | CN1327822A Universal red Zn-base ointment for treating injury and its prparing process |
12/26/2001 | CN1327821A Capsule for treating cough and asthma |
12/26/2001 | CN1327809A Process for preparing antitussive mixture |
12/26/2001 | CN1327805A Chinese medicine 'Chuncao Xiongbitong' for treating asthma |
12/26/2001 | CN1327799A Mixture of white pepper and borneol and its application |
12/26/2001 | CN1076624C Nasally administrable compositions |
12/26/2001 | CN1076618C Liquid medicine for treating wound and pain and preparing process thereof |
12/26/2001 | CN1076616C Pure natural health-care article for eliminating smoke harm |
12/25/2001 | US6333361 Pharmaceutical composition containing zafirlukast |
12/25/2001 | US6333354 Synergistic combination of PDE inhibitors and adenylate cyclase agonists or guanyl cyclyse agonists |
12/25/2001 | US6333341 Tumor necrosis factor, antiinflammatory agents and analgesics |
12/25/2001 | US6333334 Use of macrolide compounds for the treatment of ARDS |
12/25/2001 | CA2217950C Metered dose inhaler for albuterol |
12/25/2001 | CA2184582C Pharmaceutically acceptable dnase formulation |
12/20/2001 | WO2001096547A2 Human kinases |
12/20/2001 | WO2001096546A2 Protein phosphatases |
12/20/2001 | WO2001096397A2 Cd154 variants and uses thereof |
12/20/2001 | WO2001096385A1 Codon optimised recombinant dermaphagoides allergens |
12/20/2001 | WO2001096336A2 6,5-fused bicyclic heterocycles |
12/20/2001 | WO2001096331A1 Lactam inhibitors of factor xa and method |
12/20/2001 | WO2001096330A2 Thrombin receptor antagonists |
12/20/2001 | WO2001096323A1 Serine protease inhibitors |
12/20/2001 | WO2001096305A1 Serine protease inhibitors |
12/20/2001 | WO2001096302A1 Piperidines for use as orexin receptor antagonists |
12/20/2001 | WO2001096299A2 Indole derivatives and their use as 15-lipoxygenase inhibitors |
12/20/2001 | WO2001096298A2 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
12/20/2001 | WO2001096296A1 Serine protease inhibitors |
12/20/2001 | WO2001095939A1 Novel solid dispersion compositions |
12/20/2001 | WO2001095932A1 A COMBINATION PRODUCT COMPRISING MELAGATRAN AND A FACTOR VIIa INHIBITOR |
12/20/2001 | WO2001095925A1 Pharmaceutical anti-inflammatory aerosol formulation |
12/20/2001 | WO2001095910A1 Imidazopyridine and imidazopyrimidine antiviral agents |
12/20/2001 | WO2001095903A1 5-ht3 receptor antagonists for treatment of disorders involving airway constriction |
12/20/2001 | WO2001095902A1 A composition comprising a combination of receptor agonists and antagonists |
12/20/2001 | WO2001095886A1 Bioavailable dosage form of isotretinoin |
12/20/2001 | WO2001095885A1 Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrin antagonist |
12/20/2001 | WO2001095883A1 Novel pharmaceutical formulation suitable for nebulisation |
12/20/2001 | WO2001095882A1 Novel aqueous anti-inflammatory pharmaceutical formulation |
12/20/2001 | WO2001095881A1 Pharmaceutical anti-inflammatory aerosol formulation |
12/20/2001 | WO2001095880A1 Novel pharmaceutical formulation suitable for nebulisation |
12/20/2001 | WO2001095879A1 Novel aqueous anti-inflammatory pharmaceutical formulation |
12/20/2001 | WO2001095785A2 Modulation of immune response and methods based thereon |
12/20/2001 | WO2001062933A3 Muteins of interleukin-13 (il-13) |
12/20/2001 | WO2001058896A8 Benzoxazole derivatives as tnf and pde iv inhibitors |
12/20/2001 | WO2001049689A3 NOVEL SUBSTITUTED PYRAZOLO[4,3-e]DIAZEPINES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, USE AS MEDICINAL PRODUCTS AND PROCESSES FOR PREPARING THEM |
12/20/2001 | WO2001048208A3 Streptococcus pyogenes virulence genes and proteins and their use |
12/20/2001 | WO2001039745A3 Aerosol composition comprising formoterol |
12/20/2001 | WO2001031016A3 Processed human chemokines phc-1 and phc-2 |
12/20/2001 | US20010053782 Pyrrolo[2,3-d]pyrimidine compounds |
12/20/2001 | US20010053763 Method and composition for modulating an immune response |
12/20/2001 | US20010053758 Methods and compositions for the treatment and prevention of lung disease |
12/20/2001 | US20010053351 Inhibition of GSK-3 beta |
12/20/2001 | CA2412462A1 6,5-fused bicyclic heterocycles |
12/20/2001 | CA2412327A1 Imidazopyridine and imidazopyrimidine antiviral agents |
12/20/2001 | CA2412216A1 Lactam inhibitors of factor xa and method |
12/20/2001 | CA2411805A1 Serine protease inhibitors |
12/20/2001 | CA2411798A1 Serine protease inhibitors |
12/20/2001 | CA2411495A1 1,2,4-trisubstituted benzenes as inhibitors of 15-lipoxygenase |
12/20/2001 | CA2411472A1 Cd154 variants |
12/20/2001 | CA2411231A1 Codon optimised recombinant dermaphagoides allergens |
12/20/2001 | CA2411116A1 Indole derivatives and their use as 15-lipoxygenase inhibitors |
12/20/2001 | CA2410610A1 Human kinases |
12/20/2001 | CA2410228A1 A combination product comprising melagatran and a factor viia inhibitor |
12/20/2001 | CA2409315A1 Protein phosphatases |
12/20/2001 | CA2382065A1 Bioavailable dosage form of isotretinoin |
12/19/2001 | EP1164145A2 Non-anticoagulant desulfated heparins as medicaments |
12/19/2001 | EP1163910A1 Preventives/remedies for interstitial pneumonia and pulmonary fibrosis |
12/19/2001 | EP1163909A2 Use of sugar ethers as immunity adjuvant in vaccine compositions, therapeutic compositions containing them and their use as vaccine |
12/19/2001 | EP1163904A1 Composition for the prevention of smooth muscle diseases comprising ascorbate, arginine and magnesium |
12/19/2001 | EP1163523A1 Method for detecting predisposition to a venous thromboembolic disease |
12/19/2001 | EP1163356A1 Retroviral vectors comprising functional and non-functional splice donor and splice acceptor sites |
12/19/2001 | EP1163342A1 Chlamydia antigens and corresponding dna fragments and uses thereof |
12/19/2001 | EP1163336A2 Vertebrate protein slit, dna sequence encoding it and uses thereof |
12/19/2001 | EP1163335A1 MATERIALS AND METHODS RELATING TO MODULATION OF p66 EXPRESSION |
12/19/2001 | EP1163333A2 Inhibitors of endothelin-1 synthesis |
12/19/2001 | EP1163332A1 48 human secreted proteins |
12/19/2001 | EP1163267A1 47 human secreted proteins |
12/19/2001 | EP1163242A2 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
12/19/2001 | EP1163239A1 Modified amino-acid amides as cgrp antagonists |
12/19/2001 | EP1163238A1 Chemokine recpetor binding heterocyclic compounds |
12/19/2001 | EP1163237A1 Amide derivatives |
12/19/2001 | EP1163236A1 Aromatic heterocyclic compounds as anti-inflammatory agents |
12/19/2001 | EP1163227A1 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them |
12/19/2001 | EP1163226A1 Polysubstituted 6-phenylphenanthridines with pde-iv inhibiting activity |
12/19/2001 | EP1163213A1 Hydroxamic and carboxylic acid derivatives |
12/19/2001 | EP1163212A1 Amide derivatives |
12/19/2001 | EP1163003A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist |
12/19/2001 | EP1163000A2 Vaccine against antigens from bacteriae |
12/19/2001 | EP1162999A2 Vaccine against Streptococcus pneumoniae |
12/19/2001 | EP1162998A2 Vaccine against streptococcus pneumoniae capsular polysaccharides |
12/19/2001 | EP1162990A1 Treatment with small peptides to effect antifibrotic activity |
12/19/2001 | EP1162983A1 Vaccine for house dust mite allergen using naked plasmid dna |
12/19/2001 | EP1162970A2 Anti-inflammatory uses of manzamines |
12/19/2001 | EP1162964A1 Treatment of pulmonary hypertension |
12/19/2001 | EP1094816A4 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists |
12/19/2001 | EP0828742B1 Diazepino-indoles as phosphodiesterase iv inhibitors |
12/19/2001 | EP0785781B1 Use of indole derivatives for the treatment of dermatological disorders peripheral neuropathied, arthritis, allergic or chronic obstructive airways disease, glaucoma and ocular inflammation |
12/19/2001 | EP0707849B1 Use of derivatives of 2,4-disubstituted phenols as 5-lipoxigenase inhibitors |
12/19/2001 | CN1327452A Fibroblast growth factor with hepatocyte proliferation activity |